PMA device
Amplatzer Multi-Fenestrated Septal Occluder ? ?cribriform? Occluder
Abbott Medical · Occluder, Patent Ductus, Arteriosus (MAE, Class III) · First FDA decision Sep 21, 2006, newest Sep 21, 2006Congenital heart disease
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
1
Naming "Amplatzer Multi-Fenestrated Septal"
MAUDE reports
270
Brand "Amplatzer Multi-Fenestrated Septal", since 2015
PubMed studies
5
Mentioning "Amplatzer Multi-Fenestrated Septal"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Amplatzer Multi-Fenestrated Septal Occluder ? ?cribriform? Occluder
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
P000039-S013 · Decided Sep 21, 2006 · 304 days after receipt · Normal 180 Day Track
Device type: OCCLUDER, PATENT DUCTUS, ARTERIOSUS (MAE) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Amplatzer Multi-Fenestrated Septal", any status and sponsor, newest update first.
- Abbott Structural Heart Device RegistryRecruiting
Abbott Medical DevicesPublic (ABT)
NCT06590467 · 2,500 participants (planned) · Start Aug 21, 2024 · Primary completion Dec 2029
Device: Amplatzer™ Occlusion Devices; Epic™ Surgical Tissue Heart Valve devices · For: Heart Diseases; ASD - Atrial Septal Defect; VSD - Muscular Ventricular Septal Defect and 3 more
Sites: Los Angeles, California; Washington D.C., District of Columbia; Miami, Florida · 36 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Amplatzer Multi-Fenestrated Septal", and for the whole product code for context.
This brand
270 reports: 221 malfunction, 48 injury, 1 death
Whole product code MAE
989 reports: 371 malfunction, 557 injury, 61 death
Newest reports for this brand
2135147-2026-07233 · Received Oct 27, 2026 · Event dated Oct 2, 2026
Device type: Transcatheter Septal Occluder (MLV)
Device problem as coded: Difficult to Fold, Unfold or Collapse
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2192-2008 · Started Apr 25, 2008 · Posted by FDA Sep 3, 2008
Reason given: AGA Medical Corporation has identified an issue with outer pouch seal integrity within one production lot of 10 French 45/80 delivery systems and one lot of 24 mm Sizing Balloon. We have not observed incomplete seals with the inner pouch. An intact inner pouch seal will maintain device sterility. AGA is asking that...
Cause as FDA categorized it: Packaging process control
1 more recall records with a free account
Published research
The most relevant PubMed records for "Amplatzer Multi-Fenestrated Septal"[tiab]. The summary above synthesizes these.
- Bronchopulmonary fistula closure with an Amplatzer Multi-Fenestrated Septal Occluder.
Boudoulas KD, Elinoff J, Resar JR · Catheter Cardiovasc Interv · 2010Case Reports
- Predictors of survival following trans-catheter aortic valve closure for left ventricular assist device associated aortic insufficiency.
Retzer EM, Sayer GT, Fedson SE, et al. · Catheter Cardiovasc Interv · 2016
- Transcatheter closure of patent foramen ovale associated with atrial septal aneurysm with Amplatzer Cribriform septal occluder.
Musto C, Cifarelli A, Pandolfi C, et al. · J Invasive Cardiol · 2009
- Percutaneous closure of multiple ventricular septal defects: simultaneous use of muscular ventricular septal defect device and Multi-Fenestrated Septal Occluder - "Cribriform" to close residual ventricular septal defects after complex cardiac surgery in a child.
Maiya SS, Patel SV, Reddy C, et al. · Cardiol Young · 2017Case Reports
- The use of two Amplatzer "Cribriform" Septal Occluders to close multiple postinfarction ventricular septal defects.
Szkutnik M, Kusa J, Bialkowski J · Tex Heart Inst J · 2008Case Reports
Other devices of this type
Also filed under product code MAE.
- Amplatzer Duct Occluder, Amplatzer Duct Occluder II, Amplatzer Piccolo OccluderAbbott Medical · PMA 2024
- Amplatzer Septal Occluder,cribriform Ocluder,and Delivery and Exchange SystemsAbbott Medical · PMA 2016
- Nit-Occlud PdaPfm Medical, Inc. · PMA 2024
- Amplatzer Piccolo OccluderAbbott Medical · PMA 2023
- Pma Nit-Occlud PdaPfm Medical, Inc. · PMA 2016
- Amplatzer Septal Defect OccluderAbbott Medical · PMA 2015
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.